
Opinion|Videos|June 24, 2024
Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy
The panel discusses how fusion-guided biopsy can inform patient eligibility for focal therapy in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is the role of fusion-guided biopsy in determining patient eligibility for focal therapy?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
BOND-003 Cohort C: Efficacy Results
5














